Companies in Focus

Avaí Bio, Inc. acquires, creates, and develops artificial intelligence technologies while delivering full-stack IT consulting and cloud integration services.

Aleen Inc. operates as a digital wellness and well-being insights company. Its platform transforms personal wellness information into simple, personalized insights that promote greater self-awareness and balance in daily life.

GoldHaven Resources Corp. is a Canadian junior exploration company focused on acquiring and exploring highly prospective land packages in North and South America.

Lake Victoria Gold is a rapidly growing gold exploration and development company listed on the TSX Venture Exchange under the symbol LVG. Leveraging its unique position and experience, the Company is principally focused on growth and consolidation in the highly prolific and prospective Lake Victoria Goldfield in Tanzania.

Golden Goose Resources Corp. is building a strong gold portfolio anchored by the Goldfire Claims in Quebec, Canada — 83 claims covering approximately 15 kilometres within the Urban-Barry Greenstone Belt. The early-stage exploration ground is located near the Windfall Project (Gold Fields Ltd.), currently under development. The project benefits from excellent access to expanding infrastructure, including power, roads, and nearby mills, and offers first-mover advantage within an active and highly competitive discovery corridor.

QSE - Quantum Secure Encryption Corp. is a Canadian technology company specializing in post-quantum data security, encryption, and secure data infrastructure. Built around quantum-delivered entropy and zero-knowledge architecture, QSE's solutions help protect sensitive data from current cyber threats and future quantum-enabled attacks.

Doseology Sciences Inc. operates in the oral stimulant sector as a next-generation platform focused on rethinking how consumers access energy and stimulation through better-for-you formats. The Company emphasizes product innovation, intellectual property development, capacity ownership, and disciplined commercial execution, and pursues measured growth through internal development and selective strategic acquisitions.

GT Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based on its proprietary TriKE® NK cell engager platform. The TriKE® platform is designed to harness and enhance the cancer-killing abilities of a patient's immune system natural killer cells. GT Biopharma holds an exclusive worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE® technology.

VisionWave Holdings, Inc. (Nasdaq: VWAV) is focused on advanced sensing, autonomy, and AI-driven systems for defense and security applications.